NuScale Power Stock Plunges 83% Amid Renewed Investment Scrutiny

NEW YORK — Shares of NuScale Power Corp. have fallen 83% over the past year, prompting a fresh wave of investment analysis regarding the small modular reactor developer's financial viability and future prospects. The sharp decline in the stock price has placed the company under intense scrutiny from market observers evaluating whether current valuations reflect fundamental risks or present a contrarian opportunity.

Steven Porrello, a contributor to The Motley Fool, recently published an assessment of NuScale's trajectory following the precipitous drop. The analysis focuses on the divergence between the company's long-term technological ambitions and its immediate financial challenges. NuScale, which trades on the New York Stock Exchange under the ticker SMR, has faced significant headwinds as it attempts to commercialize small modular nuclear reactors (SMRs) in a shifting energy landscape.

The 83% price erosion reflects broader investor concerns regarding the timeline for deployment and the capital intensity required to bring SMR technology to market. Critics point to the company's history of project cancellations, including the withdrawal from the Idaho National Laboratory project, as evidence of execution risk. These setbacks have eroded confidence among shareholders who had anticipated a faster path to revenue generation.

Conversely, proponents argue that the current stock price may undervalue NuScale's intellectual property and regulatory progress. The company remains the first in the United States to receive design certification from the Nuclear Regulatory Commission for a small modular reactor. Analysts suggest that if NuScale can secure new partnerships or government contracts, the technology could play a pivotal role in decarbonizing industrial processes and providing baseload power.

The investment outlook hinges on several unresolved factors. The company must demonstrate its ability to reduce construction costs while navigating complex supply chain constraints. Additionally, the broader macroeconomic environment, including interest rate fluctuations and evolving clean energy policies, will significantly impact NuScale's ability to raise capital and execute its business plan.

Market participants are now divided on whether the stock represents a distressed asset or a deep-value play in the emerging nuclear sector. The debate centers on the timeline for commercialization; if deployment is delayed further, the company may face liquidity issues that could threaten its operations. However, if NuScale can pivot successfully and secure financing, the current price levels could offer substantial upside potential.

As of September 2026, no new major contracts have been announced to reverse the downward trend. Investors are watching closely for any updates on project development or strategic partnerships that might stabilize the stock. The coming months will be critical in determining whether NuScale can overcome its financial hurdles and validate the commercial promise of small modular reactors.